image image image

“SEE-DRUG ” is a FP7 - RESEARH POTENTIAL project that aims to the upgrade the Structural Biology capacities of UPAT and to the Establishment of a Center of Excellence for Structure-Based Drug Target chracterization efforts in South-Eastern EU region.
Read the Full Story

“SEE-STRUCT” is structure-oriented module of SEE-DRUG project and aims to the structural elucidation of proteins, enzymes and other interesting drug-targets. The tools offered for these efforts are a state-of-the-art high field NMR instrument of 700 MHz equipped with a highly sensitive probe and crystallization robot.
Read the Full Story

“SEE-PROT” & “SEE-PHARM” are the protein production and the preclinical evaluation of molecules, modules of SEE-DRUG project. The tools offered for these efforts are protein production and characterization facilities an upgraded confocal microscope, an intravital microscope and myographs.
Read the Full Story

High sensetivity probe
Studies in solution
3D Structure determination, mobility, protein-protein interaction, protein-drug interactions
In-cell imaging
Leica Microscope
Tandem Scanner
Additional laser
Sub-cellular ablation in live cells, protein-complexes, protein drug interactions in vivo
Crystal growth
Crystalization trials
Fast & efficient
Crystal growth optimization, screen of protein targes in paraller with NRM Spectroscopy
intravital Microscope
In vivo
Ex vivo
Drug screening for anti-inflammatory compounds, evaluation of vasoactive compounds

Stuctural Biology
NMR & Xray
2H/13C/15N labeling
Selective labeling
Conformation dynamics, Modeling Structure determination, 3D solutions & crystal models, Bioinformatics
Molecular Biology
Biochemical pathways
Protein production
High-yield protein expression, labeling & isolation for structural studies, protein biochemistry
In-cell studies
Functional imaging
Light Microscopy
FRET measurements
Studies of biomolecular functions through Advanced Light Microscopy, Sub-cellular ablations
Vascular Biology
Cell-based assays
Signaling pathways
Monitoring cell processes (migration. proliferation, apoptosis), in vivo & ex vivo assays

Expertise Exchange
Knowledge transfer
Best practices
New applications
Exchange of researchers between UPAT and partnering organizations - EU Centers of excellence
Structural Biology
Workshops and scientific meetings will be organized at UPAT, Advanced training course in NMR
Biomolecular NMR
Life Sciences
Invited talks, Meeting participation & Poster presentations by SEE-DRUG members
Brokerage Events
Meet the expers
Links with industry
Regional Authorities
Colloquia with invited speakers from academia or industry and private sector stakeholders


The overall strategic objective of the current proposal aim to strengthen and broaden the scientific reach and socio-economic impact of the University of Patras (UPAT) through the creation of a Regional Centre of Excellence for Structural Biology that emphasizes the characterization and development of bioactive molecules with therapeutic potential.This will be accomplished by the establishment of a multi-disciplinary platform of high-level scientific research that focuses on the development of bioactive molecules targeting important biochemical processes in cancer, cardiovascular and neurodegenerative diseases.

The above targets will be achieved when the existed S&T Infrastructures and expertise (Figure 1) can be integrated in a unique scientific platform in Greece and SouthEastern EU region consisting of the following modules:

SEE-PROT: Production of protein & peptides and screening/optimization of polypeptide samples, for structural and functional studies either by NMR or by X-ray and other biophysical techniques. NMR will be used to screen polypeptide samples to be used for solid-state conformational analysis, and will significantly increase the success rates of proposal applications for access to high-cost Large RIs for X-ray & High-Field NMR studies.

SEE-STRUCT: Conformational dynamics, interactions & biophysical characterization, to provide atomic-level insight on individual proteins and protein-protein/drug candidates interaction, to identify new protein-protein interactions and to investigate the physicochemical properties (dynamics, affinity, kinetics, etc) of these interactions, based on NMR methods, automated crystallization and other complementary techniques.

SEE-PHARM: Disease-modelling cell-based assays including live cell imaging techniques, complemented by ex vivo and in vivo screening, to test protein-protein/peptide and protein-drug lead interactions, evaluate efficacy of candidate molecules, determine new biomolecular interactions and study the effects of the leads on basic cellular pathways. SEE-PHARM’s role will therefore be to use all its available tools to test bio-molecules developed on NMR structure-based information and provide valuable feedback regarding their optimization

Upcoming Events

Hot off the Press

porn /div> The NMR Structure of ARKADIA RING Domain (Proteins 2012, 50, 1484-89)

H2S and NO in angiogenesis & vasodilatation (PNAS 2012 in the press)

Site Statistics

mod_vvisit_counterThis week253
mod_vvisit_counterLast week205
mod_vvisit_counterThis month712
mod_vvisit_counterLast month644
mod_vvisit_counterAll days213237

We have: 122 guests online
Your IP:
Today: Oct 22, 2019
University of Patras General Info, Services, Research Committee, etc.

FP7 Research & Innovation – Participants Portal – Calls for applications

International Meetings & Conferences

Journal Club

  • 01 Jan 2012 Starting data of SEE-DRUG project

  • 23 Feb 2012 Kick-off meeting

  • 23 Apr2012 External Advisory Board meeting

  • 29 Apr 2013 700MHz NMR installed